Angiogenic factor screening in women with mild preeclampsia - New and significant proteins in plasma

作者：Charkiewicz Karol; Jasinska Elwira; Goscik Joanna; Koc Zorawska Ewa; Zorawski Marcin; Kuc Pawel; Raba Grzegorz; Kluz Tomasz; Kalinka Jaroslaw; Sakowicz Agata; Laudanski Piotr^*

来源：Cytokine, 2018, 106: 125-130.

DOI：10.1016/j.cyto.2017.10.020

• Angiogenesis
• Apoptosis
• Angiogenic factors
• Cytokine
• Protein array
• Preeclampsia
• Placenta

Introduction: The aim of this study was to analyse a panel of 60 angiogenic factors (pro-angiogenic and anti-angiogenic) in the plasma of women with mild preeclampsia.
Materials and Methods: We recruited 21 women between 25 and 40 weeks gestation with diagnosed mild preeclampsia into the study group and 27 healthy women with uncomplicated pregnancies of corresponding gestational age to that of the study to the control group. We used a quantitative protein macroarray method that allowed for analysis of 60 angiogenic proteins per sample simultaneously.
Results: We showed a statistically significant increase in the concentration of 8 proteins, interferon gamma (IFN-gamma), interleukin 6 (IL-6), leukaemia inhibitory factor (LIF), heparin-binding EGF-like growth factor (HB-EGF), hepatocyte growth factor (HGF), C-X-C motif chemokine 10 (IP-10), leptin and platelet-derived growth factor BB (PDGF-BB), as well as a significant decrease in the concentration of 3 proteins, vascular endothelial growth factor (VEGF), placental growth factor (P1GF) and follistatin, in the plasma of women with preeclampsia.
Conclusion: Based on our findings, it seems that protein factors may play an important role in the pathogenesis of preeclampsia, and there are many proteins that have not been studied in PE to date. There are no previous studies assessing the LW, follistatin, HGF, HB-EGF and PDGF-BB concentrations in the plasma of women with PE; therefore, our obtained results indicate that these proteins are new factors that can play an important role in the pathomechanisms of PE.

• 出版日期2018-6